Table 7.
Group 4 | ACF with | Small ACF (≤3 Crypts) | Large ACF (≥4 Crypts) | ||
---|---|---|---|---|---|
1 Crypt | 2 Crypts | 3 Crypts | |||
C | 6.6 ± 2.3 a | 3.0 ± 2.3 a | 1.1 ± 1.3 a | 10.6 ± 4.3 a | 1.2 ± 1.1 a |
D | 3.7 ± 2.4 b | 2.4 ± 1.3 a | 1.2 ± 0.8 a | 7.4 ± 3.2 b | 0.6 ± 0.4 b |
DLA | 4.3 ± 1.6 b | 2.5 ± 0.7 a | 0.9 ± 0.7 a | 7.6 ± 2.0 b | — 3 |
DHA | 3.1 ± 1.6 b | 2.0 ± 1.1 a | 0.8 ± 1.1 a | 6.0 ± 2.6 b | 0.4 ± 0.5 b |
1 All values are mean ± SD (n = 12). 2 Values with the different superscript letters in a column are significantly different from one another as determined by one-way ANOVA followed by Duncan’s multiple range test, p < 0.05. 3 No ACF observed. 4 All rats were administered with DMH/DSS. C, AIN-93G diet; D, AIN-93G containing 10% djulis; DLA, AIN-93G containing 10% djulis + 5 × 106 cfu L. acidophilus/g; DHA, AIN-93G containing 10% djulis + 5 × 107 cfu L. acidophilus/g.